Persistent infection of a human lymphoblastoid cell line with equine herpesvirus 1.
Abstract: Infection of a human lymphoblastoid cell line (Jijoye line derived from a Burkitt lymphoma which contains Epstein-Barr virus) with equine herpesvirus 1, maintained and observed for 53 days, was characterized by the continuous production of infectious extracellular and intracellular virus. Maximum virus production correlated with active cell multiplication. Less than 15% of the cells possessed viral capsid antigen at any one time. Five percent of the cells in the Jijoye line possess Epstein-Barr viral capsid antigen; 80% of the Epstein-Barr viral caspid-containing cells also contained equine herpesvirus 1 antigen as detected by double staining. The interaction of equine herpesvirus 1 and lymphoblastoid cells provides a useful in vitro model which may help clarify the mechanism for herpesvirus latency.
Publication Date: 1979-05-01 PubMed ID: 222688PubMed Central: PMC414333DOI: 10.1128/iai.24.2.539-544.1979Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research investigated how the interaction between equine herpesvirus 1 and a human lymphoblastoid cell line (a type of cancer cell line) can be informative for understanding herpesvirus latency. It found that this cell line could be infected with and continually produce the equine herpesvirus 1 for over 7 weeks, with most virus production occurring when cells were actively multiplying.
Overview of the Study
- The researchers infected a human lymphoblastoid cell line known as the Jijoye line with equine herpesvirus 1. This cell line was derived from Burkitt lymphoma and contains Epstein-Barr virus.
- The infected cell line was maintained and observed over a period of 53 days.
- It was found that the cell line consistently produced both extracellular and intracellular virus throughout the observation period. The highest level of virus production occurred when the cells were actively multiplying.
Key Findings
- At any given time, less than 15% of the cells contained the viral capsid antigen, which is a protein of the virus that triggers an immune response.
- Around 5% of the cells in the Jijoye line exhibited the Epstein-Barr viral caspid antigen.
- Among the cells that contained the Epstein-Barr viral caspid, 80% also contained the equine herpesvirus 1 antigen. This was detected using a technique called double staining.
Implications of the Study
- The study provides a valuable in-vitro (in a controlled lab environment rather than in a living organism) model for studying the mechanism of herpesvirus latency. Latency refers to the ability of herpesviruses to remain dormant in a host, only to become active again under certain conditions.
- Understanding this mechanism could contribute to new treatments or preventative measures to control the impact of herpesviruses.
Cite This Article
APA
Roumillat LF, Feorino PM, Lukert PD.
(1979).
Persistent infection of a human lymphoblastoid cell line with equine herpesvirus 1.
Infect Immun, 24(2), 539-544.
https://doi.org/10.1128/iai.24.2.539-544.1979 Publication
Researcher Affiliations
MeSH Terms
- Antigen-Antibody Reactions
- Antigens, Viral / analysis
- Cell Division
- Cell Line
- Herpesviridae / growth & development
- Herpesviridae Infections / microbiology
- Herpesvirus 1, Equid / growth & development
- Humans
- Lymphocytes / microbiology
- Virus Replication
References
This article includes 14 references
- J Clin Pathol. 1965 May;18:261-73
- J Exp Med. 1965 May 1;121:761-70
- Lancet. 1964 Feb 1;1(7327):238-40
- J Natl Cancer Inst. 1970 Aug;45(2):399-406
- Acta Virol. 1971 Mar;15(2):133-42
- Appl Microbiol. 1973 Feb;25(2):315-6
- Cancer Res. 1968 Jun;28(6):1121-5
- Cancer Res. 1969 Aug;29(8):1467-75
- Cancer Res. 1969 Feb;29(2):489-94
- J Am Vet Med Assoc. 1969 Jul 15;155(2):294-300
- J Virol. 1970 Nov;6(5):699-701
- J Gen Virol. 1976 Jul;32(1):51-62
- Int J Cancer. 1975 Jul 15;16(1):125-33
- Arch Virol. 1975;49(2-3):165-74
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists